Rosiglitazone suppresses angiogenesis in multiple myeloma via downregulation of hypoxia-inducible factor-1α and insulin-like growth factor-1 mRNA expressionMingzhong Rui, Haiwen Huang|Molecular Medicine Reports|2014Cited by 13